|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.06 USD | +0.33% |
|
+2.10% | +4.16% |
| 07-01 | Collegium Pharmaceutical, Inc.(NasdaqGS:COLL) added to Russell 2000 Growth-Defensive Index | CI |
| 07-01 | Collegium Pharmaceutical, Inc.(NasdaqGS:COLL) added to Russell 2000 Defensive Index | CI |
Collegium Pharmaceutical, Inc. announced the appointment of Ted Schroeder to its board of directors. Mr. Schroeder led specialty pharmaceutical company Cadence Pharmaceuticals from its founding until its acquisition by Mallinckrodt Pharmaceuticals for $1.4 billion in 2014. Most recently, Mr. Schroeder co-founded Zavante Therapeutics.
Mr. Schroeder currently serves on the board of Cidara Therapeutics and Otonomy.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.16% | 1.05B | |
| +55.82% | 848B | |
| +31.64% | 627B | |
| -0.02% | 363B | |
| +15.51% | 318B | |
| +13.33% | 299B | |
| +15.51% | 243B | |
| +16.72% | 225B | |
| +16.52% | 179B | |
| +4.29% | 167B |
COLLEGIUM PHARMACEUTICAL, INC. 
